SCHEMBL6500940

SCHEMBL6500940

CCn1c(NC2c3ccccc3CC2OC(C)=O)c(C)nc(-c2ccc(OC)cc2Cl)c1=O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 3/20 0.41
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
MAOB P27338 1/20 0.34
GABRA1 P14867 2/20 0.34
GABRB2 P47870 2/20 0.34
POLB P06746 2/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
CDC7 O00311 1/20 0.33
DBF4 Q9UBU7 1/20 0.33
HTT P42858 1/20 0.33
NPBWR1 P48145 1/20 0.33
NTRK1 P04629 2/20 0.33
EGFR P00533 1/20 0.32
KDR P35968 1/20 0.32
SMURF2 Q9HAU4 1/20 0.32
SMURF1 Q9HCE7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5783846 1.00 CRHR1 (0.41) CRHR1MTNR1AMTNR1BMAOBGABRA1
SCHEMBL5783841 1.00 CRHR1 (0.41) CRHR1MTNR1AMTNR1BMAOBGABRA1
SCHEMBL5780328 0.92 CRHR1 (0.43) CRHR1MTNR1AMTNR1BGABRA1GABRB2
SCHEMBL5780326 0.92 CRHR1 (0.43) CRHR1MTNR1AMTNR1BGABRA1GABRB2
SCHEMBL6505605 0.92 CRHR1 (0.43) CRHR1MTNR1AMTNR1BGABRA1GABRB2
SCHEMBL5785473 0.92 CRHR1 (0.42) CRHR1POLB
SCHEMBL6506650 0.92 CRHR1 (0.42) CRHR1POLB
SCHEMBL5785470 0.92 CRHR1 (0.42) CRHR1POLB
SCHEMBL6505939 0.90 CRHR1 (0.40) CRHR1POLBCDC7DBF4HTT
SCHEMBL5782164 0.90 CRHR1 (0.39) CRHR1MTNR1AMTNR1BMAOBGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050020601-A1 Novel pyrazinones as CRF1 receptor antagonists PFIZER INC 2005-01-27 US claimed
US-20050020601-A1 Novel pyrazinones as CRF1 receptor antagonists PFIZER INC 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020601-A1 Novel pyrazinones as CRF1 receptor antagonists CRHR1, CRHR2, CRH CRHR1 1/4885MTNR1A 136/4885MTNR1B 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.